Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Management of Extremely Elevated Alkaline Phosphatase in Infant with Failure to Thrive

Initial Diagnostic Approach

  • The American Academy of Pediatrics recommends obtaining serum phosphate, calcium, parathyroid hormone (PTH), and 25-hydroxyvitamin D to evaluate for X-linked hypophosphatemia (XLH) and other phosphopenic rickets 1, 2, 3
  • The Genetics in Medicine society suggests measuring comprehensive metabolic panel including liver function tests (AST, ALT, GGT, direct and total bilirubin) to assess for hepatobiliary disease 4
  • The Genetics in Medicine society recommends obtaining complete blood count to evaluate for neutropenia (seen in Shwachman-Diamond syndrome and acid sphingomyelinase deficiency) 5, 4
  • The Nature Reviews Nephrology journal suggests measuring urinalysis with calcium-to-creatinine ratio to assess for hypercalciuria or nephrocalcinosis 6, 7

Critical Clinical Assessment

  • The Genetics in Medicine society recommends examining growth parameters, plotting weight-for-height and height-for-age z-scores, and assessing for skeletal abnormalities, such as bowing of legs, rachitic rosary, widened wrists/ankles, or genu varum/valgum indicating rickets 5, 1, 2, 8
  • The American Journal of Respiratory and Critical Care Medicine suggests assessing for hepatosplenomegaly by palpating for organomegaly suggesting lysosomal storage disease or liver pathology 4, 9

Diagnostic Algorithm Based on Initial Results

  • The Nature Reviews Nephrology journal recommends measuring TmP/GFR and FGF23 levels if serum phosphate is low with elevated ALP, indicating phosphopenic rickets, most commonly XLH 1, 8
  • The Nature Reviews Nephrology journal suggests obtaining skeletal radiographs of wrists and knees to assess for rickets 1, 2
  • The Genetics in Medicine society recommends initiating treatment immediately with oral phosphate supplements and active vitamin D if XLH is confirmed 2, 3

Monitoring During Treatment

  • The Nature Reviews Nephrology journal recommends monitoring ALP levels every 4-8 weeks during active treatment as a marker of bone healing 1, 2, 3
  • The Genetics in Medicine society suggests tracking growth velocity monthly, and measuring serum phosphate 7-11 days after dose adjustments to avoid hyperphosphatemia 5, 1, 3
  • The Nature Reviews Nephrology journal recommends checking urinary calcium-to-creatinine ratio every 3 months to prevent nephrocalcinosis, and assessing PTH levels every 3-6 months 2, 3

REFERENCES

← Return to Home